• Skip to main content
  • Skip to footer
  • UCI
  • Office of the Provost
  • Academic Initiatives
Donate
Follow IDSI on Twitter!
id science logo
  • Research
  • Publications
  • About Us
    • Leadership & Staff
    • Faculty Advisory Board
    • Affiliate Faculty
    • Contact Us
  • News
  • Events
  • Education & Training
  • Funding Opportunities
  • Resources
    • Coronavirus Disease (COVID-19) Outbreak Resources

Mayo Clinic is second commercial lab to begin monkeypox testing

You are here: Home / News & Announcements / Mayo Clinic is second commercial lab to begin monkeypox testing

July 11, 2022

Mayo Clinic is second commercial lab to begin monkeypox testing

Mayo Clinic Laboratories on Monday became the second commercial laboratory in the U.S. to begin monkeypox testing as part of an effort to increase testing capacity and access.

IDN0622Monkeypox_vaccination_Graphic_01_WEB

“The ability of commercial laboratories to test for monkeypox is an important pillar in our comprehensive strategy to combat this disease,” CDC Director Rochelle Walensky, MD, MPH, said in a press release. “This will not only increase testing capacity but also make it more convenient for providers and patients to access tests by using existing provider-to-laboratory networks.”

In addition to increased testing, the CDC has issued travel alerts and expanded access to vaccines in response to the outbreak.

WHO has so far declined to declare the outbreak a public health emergency of international concern, although an emergency committee plans to meet again on July 18 or sooner if to discuss the situation.

Read More

News & Announcements

Footer

Coronavirus Disease (COVID-19) Outbreak Resources

COVID-19

Resources

medical technology

Research

map of the world

Publications

magnifying glass
Get In Touch!

Office of Academic Planning
535 Aldrich Hall
University of California, Irvine
Irvine, CA 92697-1000

idinitiative@uci.edu

 

 

About Us

UCI Infectious Disease Science Initiative aims to position UCI as a global leader in research and education in infectious disease dynamics by fueling the development of new knowledge and insights into the dynamics of infectious diseases and drug resistance.

© 2019 UC Regents  |  Privacy Policy